Using light therapy to improve dental plaque control at home
Photodynamic Treatment in the Management of Residual Biofilm - a Crossover Study
This study is testing whether a new light therapy device can help people do a better job at controlling dental plaque at home compared to regular brushing and flossing.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Koite Health Oy Industry-sponsored |
| Locations | 1 site (Helsinki) |
| Trial ID | NCT06860321 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of a home-use dual-light antibacterial device in reducing residual biofilm compared to traditional mechanical cleaning methods. Participants will be randomly assigned to use either the dual-light device or standard oral care techniques in a crossover design. The device utilizes a photosensitive molecule activated by light to generate reactive oxygen species that target bacteria. The study aims to enhance dental hygiene practices and improve outcomes for plaque control.
Who should consider this trial
Good fit: Ideal candidates are healthy adults who can perform regular oral self-care.
Not a fit: Patients with periodontitis or those unable to maintain regular oral hygiene may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve dental hygiene and reduce plaque buildup for patients.
How similar studies have performed: Previous studies have shown positive outcomes with photodynamic therapy in dental applications, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed informed consent voluntarily * Good general health Exclusion Criteria: * Periodontitis * Inability to perform regular oral self-care
Where this trial is running
Helsinki
- Oral Hammaslääkärit, Helsinki Bulevardi — Helsinki, Finland (Recruiting)
Study contacts
- Study coordinator: Mikko Kylmänen
- Email: mikko.kylmanen@koitehealth.com
- Phone: +358407245934
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.